EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Retinal microvascular alterations in Alzheimer's disease: Linking blood plasma biomarkers and cerebral small vessel pathology

William Robert Kwapong, Ning Wu, Weihong Lin, Jianing Shen, Youjie Wang, Jiajing Qian, Caiyun Wen, Xiaoqian Luan, Yuntao Liu, Haoran Cheng, Huihua Qiu, Carol Y Cheung und 5 weitere

Alzheimer's & Dementia · 2025-10 · 21 (10)

DOI: 10.1002/alz.70745 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 09.10.2025. Verfasst von William Robert Kwapong und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Retinal Vessels, Microvessels, Cerebral Small Vessel Diseases. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Laboratory of Novel Nuclide Technologies on Precision Diagnosis, Treatment & Clinical Transformation of Wenzhou City, Zhejiang Clinovation Pride Code.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Retinal microvascular alterations, detectable via color fundus photography (CFP), may reflect cerebral microvascular pathology in Alzheimer's disease (AD). However, their associations with blood‐based biomarkers and cerebral small vessel disease (SVD) remain unclear. METHODS This cross‐sectional study included 72 AD patients and 82 cognitively unimpaired (CU) controls. Participants underwent CFP, plasma biomarker analysis (amyloid beta [Aβ]42, Aβ42/40, phosphorylated tau [p‐tau]181, p‐tau217), and 3T magnetic resonance imaging. Retinal microvascular metrics (vessel density [VD], fractal dimension [FD]) were analyzed alongside SVD markers (white matter hyperintensities [WMHs], SVD burden) and medial temporal lobe atrophy (MTA). RESULTS AD patients exhibited significantly reduced VD and FD compared to CU (all p < 0.001), with strong diagnostic accuracy (area under the curve: 0.969 for VD; 0.904 for FD). Retinal microvascular impairment correlated with plasma biomarkers (lower Aβ42, Aβ42/40; elevated p‐tau181, p‐tau217; all p < 0.05) and neuroimaging markers of SVD (WMHs, MTA; all p < 0.05). Apolipoprotein E ε4 carriers showed more severe retinal microvascular damage ( p < 0.001). DISCUSSION Retinal microvascular alterations, assayed via CFP, are linked to AD‐specific proteinopathy and cerebrovascular pathology, supporting CFP as a scalable, non‐invasive tool for AD biomarker discovery. Highlights Retinal microvasculature assayed via color fundus photography (CFP) is sensitive to microvascular damage and can differentiate Alzheimer's disease (AD) from cognitively unimpaired controls. Retinal microvascular damage in AD is associated with phosphorylated tau [p‐tau]181, p‐tau217, p‐tau217/amyloid beta (Aβ)42, and increased amyloid burden (lower Aβ42 and Aβ42/40). Retinal microvascular damage in AD is associated with increased cerebral small vessel burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseRetinal VesselsMicrovesselsCerebral Small Vessel DiseasesHumansMaleFemaleBiomarkersCross-Sectional StudiesAgedAmyloid beta-Peptidestau ProteinsMagnetic Resonance ImagingMiddle Aged

Stichwörter der Autor:innen

amyloidcerebral small vessel diseaseretinal microvasculaturetau

Substanzen

BiomarkersAmyloid beta-Peptidestau Proteins

Autor:innen und Institutionen

  • Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Department of Medical Imaging, Yanjing Medical College, Capital Medical University, Beijing, China.
  • Key Laboratory of Alzheimer's Disease of Zhejiang Province, Wenzhou, China.
  • Healthcare Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Wenzhou Key Laboratory of Intelligent Prevention and Active Health for Aging-Related Chronic Diseases, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • Department of Geriatrics, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.

Förderung

  • Key Laboratory of Novel Nuclide Technologies on Precision Diagnosis
  • Treatment & Clinical Transformation of Wenzhou City
  • Zhejiang Clinovation Pride Code

Zitieren

APA

Kwapong, W. R., Wu, N., Lin, W., Shen, J., Wang, Y., Qian, J., Wen, C., Luan, X., Liu, Y., Cheng, H., Qiu, H., Cheung, C. Y., Zheng, C., Liu, Y., Yang, Y., Mok, V., & Wang, Z. (2025). Retinal microvascular alterations in Alzheimer's disease: Linking blood plasma biomarkers and cerebral small vessel pathology. Alzheimer's & Dementia, 21(10). https://doi.org/10.1002/alz.70745

Vancouver

Kwapong WR, Wu N, Lin W, Shen J, Wang Y, Qian J, et al. Retinal microvascular alterations in Alzheimer's disease: Linking blood plasma biomarkers and cerebral small vessel pathology. Alzheimer's & Dementia. 2025;21(10). doi:10.1002/alz.70745

BibTeX
@article{Kwapong2025,
  author = {Kwapong, William Robert and Wu, Ning and Lin, Weihong and Shen, Jianing and Wang, Youjie and Qian, Jiajing and Wen, Caiyun and Luan, Xiaoqian and Liu, Yuntao and Cheng, Haoran and Qiu, Huihua and Cheung, Carol Y and Zheng, Chunwen and Liu, Yinhe and Yang, Yunjun and Mok, Vincent and Wang, Zhen},
  title = {Retinal microvascular alterations in Alzheimer's disease: Linking blood plasma biomarkers and cerebral small vessel pathology},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  volume = {21},
  number = {10},
  doi = {10.1002/alz.70745}
}
Kostenlos starten →